TY - JOUR
T1 - Healthy Tissue Uptake of Ga-68-Prostate-Specific Membrane Antigen, F-18-DCFPyL, F-18-Fluoromethylcholine, and F-18-Dihydrotestosterone
AU - Jansen, Bernard H.E.
AU - Kramer, Gem M.
AU - Cysouw, Matthijs C.F.
AU - Yaqub, Maqsood M.
AU - de Keizer, Bart
AU - Lavalaye, Jules
AU - Booij, Jan
AU - Vargas, Hebert Alberto
AU - Morris, Michael J.
AU - Vis, André N.
AU - van Moorselaar, Reindert J.A.
AU - Hoekstra, Otto S.
AU - Boellaard, Ronald
AU - Oprea-Lager, Daniela E.
N1 - © 2019 by the Society of Nuclear Medicine and Molecular Imaging.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include
68Ga-prostate-specific membrane antigen HBED-CC (
68Ga-PSMA),
18F-DCFPyL,
18F-fluoromethylcholine (
18F-FCH), and
18F-dihydrotestosterone (
18F-FDHT). Knowledge on the variability of tracer uptake in healthy tissues is important for accurate PET interpretation, because malignancy is suspected only if the uptake of a lesion contrasts with its background. Therefore, the aim of this study was to quantify uptake variability of PCa tracers in healthy tissues and identify stable reference regions for PET interpretation.
Methods: A total of 232 PCa PET/CT scans from multiple hospitals was analyzed, including 87
68Ga-PSMA scans, 50
18F-DCFPyL scans, 68
18F-FCH scans, and 27
18F-FDHT scans. Tracer uptake was assessed in the blood pool, lung, liver, bone marrow, and muscle using several SUVs (SUV
max, SUV
mean, SUV
peak). Variability in uptake between patients was analyzed using the coefficient of variation (COV%). For all tracers, SUV reference ranges (95th percentiles) were calculated, which could be applicable as image-based quality control for future PET acquisitions.
Results: For
68Ga-PSMA, the lowest uptake variability was observed in the blood pool (COV, 19.9%), which was significantly more stable than all other tissues (COV, 29.8%-35.2%;
P = 0.001-0.024). For
18F-DCFPyL, the lowest variability was observed in the blood pool and liver (COV, 14.4% and 21.7%, respectively;
P = 0.001-0.003). The least variable
18F-FCH uptake was observed in the liver, blood pool, and bone marrow (COV, 16.8%-24.2%;
P = 0.001-0.012). For
18F-FDHT, low uptake variability was observed in all tissues, except the lung (COV, 14.6%-23.6%;
P = 0.001-0.040). The different SUV types had limited effect on variability (COVs within 3 percentage points).
Conclusion: In this multicenter analysis, healthy tissues with limited uptake variability were identified, which may serve as reference regions for PCa PET interpretation. These reference regions include the blood pool for
68Ga-PSMA and
18F-DCFPyL and the liver for
18F-FCH and
18F-FDHT. Healthy tissue SUV reference ranges are presented and applicable as image-based quality control.
AB - PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include
68Ga-prostate-specific membrane antigen HBED-CC (
68Ga-PSMA),
18F-DCFPyL,
18F-fluoromethylcholine (
18F-FCH), and
18F-dihydrotestosterone (
18F-FDHT). Knowledge on the variability of tracer uptake in healthy tissues is important for accurate PET interpretation, because malignancy is suspected only if the uptake of a lesion contrasts with its background. Therefore, the aim of this study was to quantify uptake variability of PCa tracers in healthy tissues and identify stable reference regions for PET interpretation.
Methods: A total of 232 PCa PET/CT scans from multiple hospitals was analyzed, including 87
68Ga-PSMA scans, 50
18F-DCFPyL scans, 68
18F-FCH scans, and 27
18F-FDHT scans. Tracer uptake was assessed in the blood pool, lung, liver, bone marrow, and muscle using several SUVs (SUV
max, SUV
mean, SUV
peak). Variability in uptake between patients was analyzed using the coefficient of variation (COV%). For all tracers, SUV reference ranges (95th percentiles) were calculated, which could be applicable as image-based quality control for future PET acquisitions.
Results: For
68Ga-PSMA, the lowest uptake variability was observed in the blood pool (COV, 19.9%), which was significantly more stable than all other tissues (COV, 29.8%-35.2%;
P = 0.001-0.024). For
18F-DCFPyL, the lowest variability was observed in the blood pool and liver (COV, 14.4% and 21.7%, respectively;
P = 0.001-0.003). The least variable
18F-FCH uptake was observed in the liver, blood pool, and bone marrow (COV, 16.8%-24.2%;
P = 0.001-0.012). For
18F-FDHT, low uptake variability was observed in all tissues, except the lung (COV, 14.6%-23.6%;
P = 0.001-0.040). The different SUV types had limited effect on variability (COVs within 3 percentage points).
Conclusion: In this multicenter analysis, healthy tissues with limited uptake variability were identified, which may serve as reference regions for PCa PET interpretation. These reference regions include the blood pool for
68Ga-PSMA and
18F-DCFPyL and the liver for
18F-FCH and
18F-FDHT. Healthy tissue SUV reference ranges are presented and applicable as image-based quality control.
KW - Healthy tissue
KW - PET interpretation
KW - Prostate cancer
KW - PSMA
UR - http://www.scopus.com/inward/record.url?scp=85071055653&partnerID=8YFLogxK
U2 - 10.2967/jnumed.118.222505
DO - 10.2967/jnumed.118.222505
M3 - Article
C2 - 30630941
AN - SCOPUS:85071055653
SN - 0161-5505
VL - 60
SP - 1111
EP - 1117
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 8
ER -